NCT01272037 2026-04-13
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Gustave Roussy, Cancer Campus, Grand Paris
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Institute of Oncology Ljubljana
Nationwide Children's Hospital
Rutgers, The State University of New Jersey